Director, Worldwide Medical Oncology, Medical Communications

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

We are seeking a WWMO Medical Communications Director with a deep understanding of the relevant disease states, medical education, scientific customer experience and communication within WWMO. In this exciting role you will be responsible for creating scientific communication strategic plans for the specific disease areas, publication tactics, materials for scientific exchange, scientific narrative and platform, and external communication tools in alignment with the business needs within Medical Affairs and Clinical Development. The Director will be responsible for building and fostering relationships across the alliance partners and ensuring alignment and pull through of the strategy across the medical communication plans.

Position reports to the Director of Thoracic, H&N Medical Communications within WWMO, Global Medical Affairs and is responsible for the strategy and execution of Pumitamig (BNT327/BMS986545) medical communication plans and execution of high quality, medical communications to ensure pull-through of the Scientific Narrative across multiple potential therapy areas (i.e. lung, breast, GI).

Key Responsibilities

Alliance Partnership:
 

Collaborate effectively with the alliance partner to drive joint initiatives, ensure alignment on strategic objectives, and facilitate seamless communication across cross-functional teams.

Medical Communications Strategy:

• Managing across a global matrix organization to drive quality planning and timely communication of key scientific information for BMS assets within specified therapeutic area.
• As a core member of the respective AIMS team, responsible for establishing a clear, viable and compelling strategy for TA-specific Medical Communications, aligned with overall WWMO vision, strategy and objectives, and ensure delivery of timely and high-quality medical publications, scientific content, medical education and congress presentations worldwide.
• Responsible for chairing the Medical Communications Working Group, a critical AIMS sub-team, and the delivery associated AIMS deliverables (3-year strategic/18-month tactical Medical Communications plan and Scientific Narrative & Platform)
• Own the development, pull-through and execution of the Scientific Narrative aligned with portfolio strategy, development & execution of functionally integrated publication plan, content plan, and application to the Scientific Communication Platform (SCP).
• Lead development of personalized medical communications and ensure timely journal submissions, publications, Congress presentations, and deliver of internal and external scientific content.
• Leverage digital, omnichannel tools, and AI-driven solutions to innovate and enhance Medical Communication strategies, ensuring impactful and data-driven engagement with healthcare professionals and stakeholders
• Must have strong business acumen, ability to interface with matrix partners to make trade-off decisions by managing Medical Communications Asset/Indication-level budget and allocation of funds and resources to highest business priorities.

Data Dissemination:

• Serve as a subject matter expert to BMS internal audiences related to Asset/Indication-level communication landscape, HCP preferences, publication and scientific content planning, data disclosure / dissemination, and represent BMS scientific communications to external investigators, key authors and journal editors.
• Leading internal process improvements to ensure BMS remains an ethical and credible leader in the practice of publications & scientific content; leading transformation efforts worldwide and for ensuring BMS publication & scientific c